Your weekly update on top ETF trends
 | FRI, AUG 26, 2022 | | | |
| | | YOUR WEEKLY UPDATE ON TOP ETF TRENDS | | | | |
With the Fed on the warpath against inflation, even risking a recession, what's the right move for investors? Join me on ETF Edge this Monday, when my guests will be Wes Crill, Dimensional Funds' Head of Investment Strategists, and Dave Nadig, Financial Futurist for VettaFi. Dimensional has $900 billion in assets under management, including a suite of ETF products. Crill and Nadig will address: the Case for Global Diversification (and should China be considered a separate case?), why the run in value stocks is not over, why dividend stocks may not be the most efficient solution to tough markets, and the right long-term way to view this year's 15% decline in the market. Also: What's right — and wrong — about the single stock ETF craze? Monday at 1 PM ET at ETFedge.cnbc.com. Even in August, there are new ETFs. On Friday, Invesco added to its suite of commodities ETF with the Invesco Agriculture Commodity Strategy No K-1 ETF (PDBA), which has exposure to 11 different grains, soft commodities, and livestock, all while bypassing the need for a K-1 tax form. And BlackRock launched the iShares Neuroscience and Healthcare ETF (IBRN), the first ETF focused on neuroscience and the growth and innovation related to the treatment of neurological diseases. High Yield ETFs seeing outflows, again. Shares outstanding of two of the largest high yield funds, the SPDR Bloomberg High Yield Bond ETF (JNK) and the iShares High Yield Corporate Bond ETF (HYG), have both seen declines of about 10% in the past week as bond yields have risen. Still, it's not nearly as bad as the January-April rout, which saw shares outstanding decline by as much as 30% as investors looked to sell their high yield holdings in what looked like an imminent recession. |
For more analysis and actionable insights, catch me live this Monday at 1 PM ET on ETF Edge. |
|
|
|
EmoticonEmoticon